Tomer Glottman, CEO
AI-based image processing – combination of text and image processing to pinpoint missed findings that can lead to increased risk and malpractice.
Srulik Dvorsky, CEO
Financial management platform – project patients’ out-of-pocket expenses and identify alternative methods of payment to reduce hospitals’ uncollectable accounts and patient debt.
Gilat Schreiber, CEO
Digital health – mobile phone add-on to facilitate primary care tests at home for telehealth services.
Keren Sela, CEO
Digital health – passively monitoring behavioral parameters of migraine patients through the smartphone in order to predict migraine attacks.
Eli David, CEO
Oral care technology – home device that provides ozonated water to treat gum diseases.
Elad Brod, CEO
Cancer diagnostic – platform for multi-faceted analysis of multiple cancer tumor cells in parallel to assess heterogeneity of tumors.
Jessica Weiss, CEO
Microsurgery technology – novel design of stitching needle and device for anastomosis of small blood vessels.
Asher Kuper, CEO
Respiratory diagnostics – portable device that assesses residual lung volume and replaces body box plethysmography.
Doron Avraham, CEO
Imaging – radiation reduction in CT – introducing optics to ionizing radiation aiming at reducing radiation exposure in CT by 50%.
Tzur Di-Cori, CEO
Digital health – disease management technology for Asthma and COPD – ultra low-cost spirometry solution using mobile app.
Drug delivery – combining the short treatment time of an inhaler with the efficiency of a nebulizer.
Companies awaiting Innovation Authority approval
Reuven Edri, Founder
3D Bio-Printing – unique 3D high resolution bio-printing technique to render the scaffold required for generating a self-populated organ to improve outcomes for organ transplants.
Tal Oren, CEO
Point of care complete blood count – provide point of care blood count analysis to assist in assessment of viral vs bacterial infection, chemotherapy readiness for oncology patients and status of anemia/cycle cell anemia.
David Smadj, MD, CEO
Opthamological intervention – leveraging nano technology in eye drops to correct for common vision impairments.
